Is ogen a good buy

Oragenics Inc (OGEN) does not appear to be a good buy at this time, and here's why:

1. Analyst Ratings and Price Targets: There is no consensus rating or average price target available for OGEN as of September 20, 2024. This lack of analyst coverage or interest could indicate a speculative or risky investment.

2. Technical Indicators: The stock's support level is not narrow enough to indicate a strong floor, and the resistance level is also missing. This could suggest that the stock is currently without clear technical boundaries, which is often a red flag for investors.

3. Recent Performance: OGEN has experienced a significant drop in its stock price, losing 82.44% year-to-date. This underperformance compared to the average annual return of -70.43% indicates that the stock has not only declined but has done so at a faster rate than the market average.
4. Financial Health Concerns: The company has a negative net fund flow of $-4718.42, which suggests that more money is leaving the stock than entering, indicating a lack of investor confidence.

5. Market Sentiment: The sentiment around OGEN is bearish, with a fear and greed index showing 39 (Fear), indicating that investors are fearful and not optimistic about the stock's future performance.
6. Long-term Outlook: The long-term predictions for OGEN are highly speculative and show potential for significant growth, but these projections are based on historical average yearly growth rates that may not be indicative of future performance.
7. Recent Public Offering: The company recently closed a public offering, which could indicate a high level of dilution and may negatively impact the stock price.

In conclusion, while there is potential for growth based on historical averages, the current technical indicators, analyst sentiment, and recent performance suggest that OGEN is not a good buy at this time. Investors should exercise caution and consider these factors before making an investment decision.